PPAR gamma as a metabolic regulator: insights from genomics and pharmacology
- PMID: 15673477
- DOI: 10.1017/S1462399405008793
PPAR gamma as a metabolic regulator: insights from genomics and pharmacology
Abstract
Since its identification in the early 1990 s, peroxisome-proliferator-activated receptor gamma (PPAR gamma), a nuclear hormone receptor, has attracted tremendous scientific and clinical interest. The role of PPAR gamma in macronutrient metabolism has received particular attention, for three main reasons: first, it is the target of the thiazolidinediones (TZDs), a novel class of insulin sensitisers widely used to treat type 2 diabetes; second, it plays a central role in adipogenesis; and third, it appears to be primarily involved in regulating lipid metabolism with predominantly secondary effects on carbohydrate metabolism, a notion in keeping with the currently in vogue 'lipocentric' view of diabetes. This review summarises in vitro studies suggesting that PPAR gamma is a master regulator of adipogenesis, and then considers in vivo findings from use of PPAR gamma agonists, knockout studies in mice and analysis of human PPAR gamma mutations/polymorphisms.
Similar articles
-
Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):501-23. doi: 10.1016/j.beem.2005.10.001. Best Pract Res Clin Endocrinol Metab. 2005. PMID: 16311214 Review.
-
Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):331-45. doi: 10.1007/s00005-008-0037-y. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18836859 Review.
-
Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.Circ Res. 2008 Feb 15;102(3):283-94. doi: 10.1161/CIRCRESAHA.107.164384. Circ Res. 2008. PMID: 18276926 Review.
-
Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.Vascul Pharmacol. 2006 Jul;45(1):29-35. doi: 10.1016/j.vph.2005.11.013. Epub 2006 Jun 14. Vascul Pharmacol. 2006. PMID: 16777491 Review.
-
PPAR-gamma receptor agonists--a review of their role in diabetic management in Trinidad and Tobago.Mol Cell Biochem. 2004 Aug;263(1-2):189-210. Mol Cell Biochem. 2004. PMID: 15524180 Review.
Cited by
-
In-Vitro-Generated Hypertrophic-Like Adipocytes Displaying PPARG Isoforms Unbalance Recapitulate Adipocyte Dysfunctions In Vivo.Cells. 2020 May 21;9(5):1284. doi: 10.3390/cells9051284. Cells. 2020. PMID: 32455814 Free PMC article.
-
Comparative genomics and transcriptomics of Chrysolophus provide insights into the evolution of complex plumage coloration.Gigascience. 2018 Oct 1;7(10):giy113. doi: 10.1093/gigascience/giy113. Gigascience. 2018. PMID: 30192940 Free PMC article.
-
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.Cell Metab. 2006 Oct;4(4):303-11. doi: 10.1016/j.cmet.2006.09.003. Cell Metab. 2006. PMID: 17011503 Free PMC article.
-
PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.Endocrinology. 2013 Dec;154(12):4803-13. doi: 10.1210/en.2013-1168. Epub 2013 Sep 24. Endocrinology. 2013. PMID: 24064359 Free PMC article.
-
Mechanisms of current therapies for diabetes mellitus type 2.Adv Physiol Educ. 2012 Dec;36(4):275-83. doi: 10.1152/advan.00094.2012. Adv Physiol Educ. 2012. PMID: 23209008 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources